Result: Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

*Title*:

*Author/editor-in-chief*:

*Corporate*:

*Publication*:

Freiburg : Universität, 2019

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Haematologica. - 99, 9 (2014) , 1441-1447, ISSN: 1592-8721

*DOI*:

10.3324/haematol.2013.096537

*Result*: Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib